echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > AAN publishes guidelines for the treatment of painful diabetic neuropathy

    AAN publishes guidelines for the treatment of painful diabetic neuropathy

    • Last Update: 2022-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    AAN releases guidelines for the treatment of painful diabetic neuropathy


    Diabetic neuropathy refers to nerve damage caused by diabetes, which can cause pain and numbness, usually in the hands and feet


    "Living in pain can greatly affect a person's quality of life, so this guideline aims to help neurologists and other doctors provide the highest quality patient care based on the latest evidence," said guide author Brian C.


    The guide points out that there are many oral and topical drugs that can effectively alleviate nerve pain


    In order to reduce nerve pain, the guidelines suggest that doctors can provide treatment for the following drug categories: tricyclic antidepressants (TCAs), such as amitriptyline, nortriptyline, and imipramine; serotonin-norepinephrine reuptake Inhibitors (SNRIs), such as duloxetine, venlafaxine, or devenlafaxine; gabapentin drugs such as gabapentin or pregabalin; and/or sodium channel blockers, such as carbamazepine, oxcarbazepine , Lamotrigine or Lacosamide


    Callaghan said: "Since the release of the last guideline, new research on sodium channel blockers has led to these drugs being now recommended and considered as effective in relieving pain, just like the other drugs recommended in the guideline


    When prescribing, the guidelines state that doctors should consider the cost of the drug, side effects, and other medical problems that the patient may have


    If the first tried drug does not provide meaningful improvement, or if there are significant side effects, the guidelines state that doctors should provide patients with a trial of another drug in a different category


    The guidelines state that opioids should not be considered for treatment


    Callahan said: "The current evidence suggests that the risks of using opioids in the treatment of painful diabetic neuropathy outweigh the benefits, so this drug should not be prescribed


    The guide states that doctors may provide topical treatments, such as capsaicin, glycerol trinitrate spray, or colomycin to relieve pain


    Callahan said: "It is worth noting that the drugs and topical treatments recommended in the guidelines may not eliminate pain, but they have been shown to reduce pain


    In order to further assist neurologists and other doctors in the treatment of painful diabetic neuropathy, AAN has also released a new AAN polyneuropathy quality measurement set, which is released together with this guide



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.